Trial Profile
Dynamics of integrated and total HIV1-DNA in patients treated with a raltegravir-containing regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 04 Sep 2015 New trial record